Intravenous levetiracetam terminates refractory focal status epilepticus

Nicholas S Abend; Nicole Florance; Richard S Finkel; Daniel J Licht; Dennis J Dlugos

doi:10.1007/s12028-007-9044-9

Intravenous levetiracetam terminates refractory focal status epilepticus

Neurocrit Care. 2009;10(1):83-6. doi: 10.1007/s12028-007-9044-9.

Authors

Nicholas S Abend¹, Nicole Florance, Richard S Finkel, Daniel J Licht, Dennis J Dlugos

Affiliation

¹ Division of Neurology, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA. abend@email.chop.edu

PMID: 18181032
DOI: 10.1007/s12028-007-9044-9

Abstract

We report a 23-year-old with complex partial status epilepticus, possibly related to underlying stroke-like migraine attacks after radiation therapy syndrome, that was refractory to benzodiazepines and phenytoin but was terminated by administration of intravenous levetiracetam.

Publication types

Case Reports

MeSH terms

Anticonvulsants / administration & dosage*
Humans
Infusions, Intravenous
Levetiracetam
Male
Piracetam / administration & dosage
Piracetam / analogs & derivatives*
Status Epilepticus / drug therapy*
Status Epilepticus / pathology
Status Epilepticus / physiopathology
Young Adult

Substances

Anticonvulsants
Levetiracetam
Piracetam